Scarica l'app Stockscreener
0.2757
0.68%
-0.0019
Pre-mercato:
.28
0.0043
+1.56%
IGC Pharma Inc Borsa (IGC) Ultime notizie
IGC Reaches Enrollment Milestone in Alzheimer's Dementia Trial - GuruFocus
IGC Pharma (NYSE American: IGC) Alzheimer's Drug Gains Attention After Ascendiant Capital Raises Price Target - openPR.com
IGC Pharma (IGC) Inches Up 1.78% as It Approaches Key ResistanceSwing Entry Signals - newsline.com
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight - 富途牛牛
IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis - The Daily Corinthian
Alzheimer's agitation drug study nears final data as IGC enrolls 146 patients - Stock Titan
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts - BioSpace
IGC Maintained by Ascendiant Capital -- Price Target Raised to $5.50 - GuruFocus
IGC Pharma Extends and Amends $12 Million Loan Facility - TipRanks
IGC Pharma Extends $12 Million O-Bank Credit Facility; Increases Fee to $60,000 - TradingView
IGC Pharma (NYSE: IGC) extends $12M O-Bank loan facility with higher fee - Stock Titan
IGC Pharma, Inc. Enters Into Amendment To Extend Master Loan And Security Agreement With O-Bank Co., Ltd - marketscreener.com
Listed NanoCaps: PMI, IGC, WTC, WOK, SELX Radar Stocks to Watch Now! - openPR.com
Stocks to Watch: ANY, CMND, PRFX, OLOX, IGC Data Centers, AI, Quantum & Healthcare - FinancialContent
IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis - Black Hills Pioneer
IGC Technical Analysis | Trend, Signals & Chart Patterns | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Pharma Expands CALMA Trial with New Site at Mount Sinai - GuruFocus
IGC Pharma Adds Mount Sinai as CALMA Trial Nears Readout - ACCESS Newswire
IGC Pharma's (NYSE: IGC) CEO Appears on Bloomberg TV Discussing - openPR.com
IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks Inside - Barchart.com
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medi - Newswire.com
IGC Pharma Holds Steady at $0.29 as Stock Consolidates Near Key LevelsMoney Flow - The Legal Advocate
IGC Q1 2026 Earnings: Narrowing Losses on Lower Expenses as EPS Surprises to the UpsideEarnings Volatility Report - newsline.com
Alzheimer's AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in FocusMore Stocks Inside - openPR.com
Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside - Carroll County Mirror-Democrat
Daily Penny AlertsAlzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside - FinancialContent
IGC Pharma (IGC) Hovers Near Support After Modest Gain, Awaiting BreakoutETF NAV Deviation - newsline.com
IGC Q1 2026 Earnings: EPS Surpasses Estimates by 14.16% Amid Revenue ChallengesEarnings Revision Report - The Legal Advocate
IGC Pharma Q1 2026 Earnings: Narrower Loss Beats Estimates; Shares Edge LowerTrading Community - Newser
IGC Q1 2026 Earnings: Narrowing Losses as Cost Discipline Drives EPS BeatEarnings Power Value - newsline.com
IGC Pharma earnings beat, revenue topped estimates By Investing.com - Investing.com Australia
IGC Pharma (IGC) Q1 2026 Earnings: $-0.02 EPS Surges Past $-0.02 EstimatesEstimate Revision Count - Newser
IGC Pharma (IGC) Delivers Q1 2026 Beat — EPS $-0.02 vs $-0.02 ExpectedForward EPS Estimate - Newser
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment - BioSpace
IGC Pharma (IGC) Q1 2026 Earnings Surprise: EPS $-0.02, Up SignificantPopular Trader Picks - Newser
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference - Black Hills Pioneer
IGC Pharma, Inc. Common Stock (NY: IGC - The Chronicle-Journal
IGC Pharma (NYSE: IGC) deepens Alzheimer’s R&D amid tight cash and new loans - Stock Titan
IGC Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
IGC Unveils Tau-PET Biomarker Study for Alzheimer's at Global Ta - GuruFocus
2.60%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):